𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Sensitivity and specificity of epstein-barr virus IGA titer in the diagnosis of nasopharyngeal carcinoma: a three-year institutional review

✍ Scribed by Raymond K. Y. Tsang; Alexander C. Vlantis; Ricky W. K. Ho; John S. L. Tam; K. F. To; C. Andrew van Hasselt

Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
413 KB
Volume
26
Category
Article
ISSN
1043-3074

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Background.

IgA antibody titers to the Epstein‐Barr virus (EBV) viral capsid antigen (EBV IgA‐VCA) and to the EBV early antigen (EBV IgA‐EA) are used to screen for nasopharyngeal carcinoma (NPC). This study evaluates the sensitivity and specificity of EBV IgA‐VCA and EBV IgA‐EA titers in screening patients for NPC and in those diagnosed with NPC at our institution.

Methods.

The NPC status was determined for all patients who had their EBV IgA‐VCA and EBV‐IgA EA titers measured over a 3‐year period, and the sensitivity and specificity were calculated.

Results.

Five thousand one hundred ninety‐six samples were analyzed. NPC was diagnosed in 215 patients. The sensitivity and specificity of a raised EBV IgA‐VCA titer (≥1:5) for diagnosing NPC were 89% and 80%, respectively, with a raised EbV IgA‐EA titer (≥1:5) having a sensitivity and specificity of 63% and 97%, respectively.

Conclusions.

Although the EBV IgA‐VCA titer is sensitive for the diagnosis of NPC, it should not be used as the sole means of screening for NPC in a population in which NPC is endemic. © 2004 Wiley Periodicals, Inc. Head Neck 26: 598–602, 2004

📜 SIMILAR VOLUMES

Epstein-Barr virus-specific antibody tit
Epstein-Barr virus-specific antibody titers in seven Alaskan Natives before and after diagnosis of nasopharyngeal carcinoma
✍ Anne P. Lanier; Werner Henle; Thomas R. Bender; Gertrude Henle; Marion L. Talbot 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 French ⚖ 431 KB 👁 1 views

## Abstract Results are presented of Epstein‐Barr virus‐specific serologic tests for seven Alaskan Native patients with nasopharyngeal carcinoma (NPC) from whom serum had been collected 2–10 years before diagnosis and up to 6 years after diagnosis. The pre‐illness antibody spectra and titers of the

Serum and salivary IgA antibodies agains
Serum and salivary IgA antibodies against a defined epitope of the Epstein-Barr virus nuclear antigen (EBNA) are elevated in nasopharyngeal carcinoma
✍ Y. T. Foong; H. M. Cheng; C. K. Sam; J. Dillner; W. Hinderer; U. Prasad 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 French ⚖ 376 KB 👁 1 views

## Abstract The Epstein‐Barr virus nuclear antigen I (EBNA I) is the only latent EBV antigen consistently expressed in malignant tissues of the nasopharynx. A 20‐amino‐acid synthetic peptide, p107 contains a major epitope of EBNA I. We tested sera from 210 patients with nasopharyngeal carcinoma (NP

IgA antibodies against the Epstein-Barr
IgA antibodies against the Epstein-Barr nuclear antigen1 as a valuable biomarker for the diagnosis of nasopharyngeal carcinoma in Tunisian patients
✍ Wajdi Ayadi; Héla Karray-Hakim; Lamia Feki; Abdelmajid Khabir; Tahia Boudawara; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 234 KB

## Abstract Serological tests for Epstein‐Barr virus (EBV) have been used for many years as diagnostic predictors of nasopharyngeal carcinoma. It has been shown previously that the conventional immunofluorescence assay has a limited diagnostic value, especially in young patients from North African